Newswire

Volastra Therapeutics Expands at Mink Building

The Mink Building

Volastra Therapeutics has signed a 40% expansion at the Mink Building in the Manhattanville Factory District, announced The Janus Property Company. In 2020, Volastra moved from an incubator at JLabs in Lower Manhattan into an 11,000-square-foot lab at the Mink Building, located on West 126th Street at Amsterdam Avenue. Volastra’s expansion now grows its space to more than 15,000 square feet.

“Janus has been an excellent partner for our operational needs. Our lab facility, purpose-built by them, is first class,” said Charles Hugh-Jones, CEO of Volastra Therapeutics, whichis focused on exploiting chromosomal instability (CIN) and its role in driving cancer metastasis. “In addition to its functionality, this location in West Harlem has enabled us to attract the top talent we need as we advance our research and our clinical programs. As we continue to expand, we are pleased to partner with Janus, which allows us to focus on the science and its impact for patients.”

Janus redeveloped the Mink Building while preserving and enhancing the building’s historic exterior. The building features expansive ceiling heights and flexible, technology-enabled office and lab settings for life sciences, TAMI, design, arts and not-for-profit tenants, among others. In 2020, Janus installed all mechanical, electrical and plumbing infrastructure to accommodate wet labs in over 70% of the building.

In addition to the Mink Building, the 1.3 million rentable square footage (rsf) Factory District includes the Sweets Building, the recently-completed Malt House and the soon-to-be-completed Taystee Lab Building.

The Manhattanville Factory District is a 1.3 million-square-foot, multi-phase, master-planned campus that includes extensive outdoor private and public space.  It spans east from Amsterdam Avenue from West 125th to West 128th Streets.

 

Sign Up for Newswire


    [ctct ctct-115 type:hidden 'Mann Report Newswire::#158']

    Advertisements